Atrophic Vaginitis: Clinical Trials

44 trials for Atrophic Vaginitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 7 unknown, 2 not yet recruiting, 2 recruiting. 13 Phase 3, 12 Not applicable, 8 Phase 4, 6 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 10, Terminated 1, Unknown 1, Withdrawn 1
Not applicable12Completed 7, Recruiting 2, Unknown 2, Active not recruiting 1
Phase 48Completed 6, Not yet recruiting 2
Phase 16Completed 3, Unknown 3
Phase 24Completed 2, Unknown 1, Withdrawn 1
Early Phase 11Completed 1

Follow this condition Literature Review of Atrophic Vaginitis trials Research Report on Atrophic Vaginitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
Vaginal estradiol tablets, Vaginal moisturizer - Menopausal Complaints, Vaginal Atrophy
Phase 4Not yet recruitingAlbert Einstein College of Medicine622026-09-012026-07-28
F-GYN for Vaginal Dryness and Vulvovaginal Atrophy
F-GYN Non-Crosslinked Hyaluronic Acid Injectable Gel, Standard Non-Hormonal Symptomatic Care - Atrophic Vaginitis, Atrophic Vulvovaginitis
Not applicableRecruitingBiovico Sp. z o.o.1302026-07-242026-10-01
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
7-940 - Vaginal Atrophy, Atrophic Vaginitis
Phase 4CompletedStratpharma AG112025-08-132026-07-20
Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women
application of the vaginal estrogen cream - Postmenopausal Atrophic Vaginitis, Genitourinary Syndrome of Menopause
Phase 4Not yet recruitingWalter Reed National Military Medical Center1102025-02-012025-02-05
Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
Atrophic Vaginitis, Gynecologic Cancer
UnknownKhon Kaen University4252024-03-142024-04-25
Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause
Vaginal Gel, Vaginal lubricant - Menopause Related Conditions, Atrophic Vaginitis
Phase 2 / Phase 3UnknownSarawak General Hospital522024-01-012023-12-28
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
7-0940 - Atrophic Vaginitis, Vaginal Atrophy
Not applicableRecruitingStratpharma AG20002023-10-302026-02-20
An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis
Film forming silicone gel (7-0940) - Atrophic Vaginitis
Not applicableCompletedStratpharma AG102022-04-012022-08-24
Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy
Photobiomodulation - Menopause, Urinary Incontinence
Not applicableCompletedCentre Hospitalier Universitaire de Nīmes252022-03-292025-12-31
Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
Conjugated Estrogens vaginal cream 0,625mg, platelet rich plasma - Atrophic Vaginitis, Postmenopausal Atrophic Vaginitis
Phase 1UnknownFayoum University1002021-11-132023-05-01
Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women
Visnadin, ethyl ximeninate, coleus barbatus and millet in emulgel, Emulgel-only - Female Sexual Function, Vulvovaginal Atrophy
Not applicableUnknownChulalongkorn University1002021-05-272024-03-22
Evaluation of Gynecological Acceptability of a Health Care Product
Health care product (intimate gel) - Atrophic Vaginitis, Vaginal Diseases
Not applicableCompletedHerbarium Laboratorio Botanico Ltda742021-04-092021-08-02
Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions
Bacterial Vaginosis, Candida Albicans Vulvovaginitis
CompletedMeir Medical Center2262020-12-012025-05-13
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
Estradiol Vaginal Insert - HIV Infection, Vaginal Atrophy
Phase 4CompletedKerry Murphy602020-09-012025-03-14
Evaluation of Gynecological Acceptability of 3 Health Care Products
Hyaluronic acid - Research product 1, Hyaluronic acid - Research product 2, Hyaluronic acid - Comparator product - Atrophic Vaginitis, Vaginal Disease
Not applicableCompletedHerbarium Laboratorio Botanico Ltda652019-11-062020-04-03
LASER and Radiofrequency and Genitourinary Syndrome of Menopause
LASER, Microablative Radiofrequency, Estriol - Postmenopausal Atrophic Vaginitis, Postmenopausal Symptoms
Not applicableActive not recruitingFederal University of São Paulo1952019-08-052025-04-22
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
Conjugated Estrogens Cream - Female Urogenital Diseases, Vaginal Atrophy
Phase 4CompletedUniversity of Alabama at Birmingham252019-08-012024-05-07
Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis
Hyalofemme, Ialuril - Atrophic Vaginitis, Urinary Tract Infections
Not applicableUnknownNewcastle-upon-Tyne Hospitals NHS Trust402019-07-012019-07-08
Effect of PRP Injection in Releiving of Symptoms of Senile Vaginitis
Platelet rich plasma - Senile Vaginitis
Phase 1UnknownAin Shams University302019-03-182019-04-02
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
Placebo, Prasterone (DHEA) - Vaginal Atrophy in Breast Cancer Patients
Phase 3WithdrawnEndoCeutics Inc.2018-11-062020-07-31

Showing 20 of 44. Sign in to see all of them.

Narrower conditions

Vaginitis (5)  ·  Aging, Premature (2)  ·  Breast Neoplasms (2)  ·  Dysbiosis (2)  ·  Dyspareunia (2)  ·  HIV Infections (2)  ·  Pelvic Organ Prolapse (2)  ·  Urinary Tract Infections (2)  ·  Vaginal Diseases (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Atrophy (1)  ·  Candidiasis, Vulvovaginal (1)  ·  Communicable Diseases (1)  ·  Dysuria (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (44)  ·  Genital Diseases (44)  ·  Genital Diseases, Female (44)  ·  Female Urogenital Diseases (43)  ·  Urogenital Diseases (43)  ·  Vaginal Diseases (42)  ·  Vaginitis (39)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Infections (6)  ·  Male Urogenital Diseases (5)  ·  Signs and Symptoms (5)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Anatomical (3)

Interventions

Dehydroepiandrosterone (6)  ·  Estradiol (6)  ·  Estriol (5)  ·  Estrogens, Conjugated (USP) (4)  ·  Vaginal Creams, Foams, and Jellies (2)  ·  Hyaluronic Acid (1)  ·  Lasers (1)  ·  Lasers, Gas (1)  ·  Low-Level Light Therapy (1)  ·  Oil and Gas Industry (1)  ·  Polyvinyl Chloride (1)  ·  Replens (1)  ·  Surveys and Questionnaires (1)  ·  promestriene (1)  ·  visnadin (1)

Sponsors

EndoCeutics Inc. (6)  ·  Stratpharma AG (4)  ·  Herbarium Laboratorio Botanico Ltda (2)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (2)  ·  AGUNCO Obstetrics and Gynecology Centre (1)  ·  Actavis Inc. (1)  ·  Ain Shams University (1)  ·  Albert Einstein College of Medicine (1)  ·  Alvogen Pine Brook LLC (1)  ·  Biovico Sp. z o.o. (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Chulalongkorn University (1)  ·  Fayoum University (1)  ·  Federal University of São Paulo (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)

Countries

United States (22)  ·  Canada (7)  ·  Brazil (3)  ·  Egypt (2)  ·  Israel (2)  ·  Thailand (2)  ·  Australia (1)  ·  Belgium (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

David F Archer, MD (3)  ·  David F Archer, M.D. (2)  ·  Kerry J Murphy, MD (2)  ·  Alfred Moffett, M.D. (1)  ·  Apiwat Jongjakapun, MD (1)  ·  Arthur Waldbaum, M.D. (1)  ·  Avraham Ben Chetrit, MD (1)  ·  Christine M Vaccaro, DO (1)  ·  Christopher Harding, MD (1)  ·  Claude Labrie, M.D., Ph.D. (1)  ·  David Archer, MD (1)  ·  Deslyn Hobson, M.D. (1)  ·  Fernand Labrie, M.D., Ph.D. (1)  ·  G. Michael Swor, M.D. (1)

Results publications

PMID 26972555, PMID 25968836, PMID 23985562, PMID 25734980, PMID 26291918, PMID 26517756, PMID 26597311, PMID 26634942, PMID 26731686, PMID 37431855, PMID 11166145, PMID 12861145, PMID 16458626, PMID 16647928, PMID 17054136, PMID 18489500, PMID 18698279, PMID 19252451, PMID 19424093, PMID 19436225, PMID 19436226, PMID 20459349, PMID 21244215, PMID 21251190, PMID 22047020, PMID 22073175, PMID 22143133, PMID 23481118, PMID 23632798, PMID 23935388, PMID 24718774, PMID 24774442, PMID 25392183, PMID 25415166, PMID 25427450, PMID 25511551, PMID 25771041, PMID 25961226, PMID 26223323, PMID 26509785, PMID 26725467, PMID 28640161, PMID 31574047, PMID 37619252, PMID 38085184, PMID 39035147, PMID 40709601, PMID 41291715, PMID 41404945, PMID 8293835

NIH funding

2019 (1), K23AG062400 (1), R01AG102277 (1), UL1TR000135 (1)